Anagnostou, Athanasius A.Sigounas, George2016-02-052016-02-051999-07-13U.S. Patent No. 5,922,674http://hdl.handle.net/10342/5166The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.Patent